Centro de Investigaciones Cardiovasculares, Consejo Nacional de Investigaciones Científicas y Técnicas-La Plata, Facultad de Medicina, Universidad Nacional de La Plata, La Plata, Argentina.
J Appl Physiol (1985). 2012 Jun;112(12):2110-20. doi: 10.1152/japplphysiol.01383.2011. Epub 2012 Apr 5.
The objective of this study was to establish whether 1) hyperactivity of renin-angiotensin-aldosterone system (RAAS) produces apoptosis in early stages of cardiac disease; and 2) Ca(2+)-calmodulin-dependent protein kinase II (CaMKII) is involved in these apoptotic events. Two models of hypertrophy were used at an early stage of cardiac disease: spontaneously hypertensive rats (SHR) and isoproterenol-treated rats (Iso-rats). At 4 mo, SHR showed blood pressure, aldosterone serum levels, used as RAAS activity index, and left ventricular mass index, used as hypertrophy index, above control values by 84.2 ± 2.6 mmHg, 211.2 ± 25.8%, and 8.6 ± 1.1 mg/mm, respectively. There was also an increase in apoptotis (Bax-to-Bcl-2 ratio and terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling positive cells) associated with an enhancement of CaMKII activity with respect to age-matched controls (phosphorylated-CaMKII, 98.7 ± 14.1 above control). Similar results were observed in 4-mo-old Iso-rats. Cardiac function studied by echocardiography remained unaltered in all groups. Enalapril treatment significantly prevented hypertrophy, apoptosis, and CaMKII activity. Moreover, intracellular Ca(2+) handling in isolated myocytes was similar between SHR, Iso-rats, and their aged-matched controls. However, SHR and Iso-rats showed a significant increase in superoxide anion generation (lucigenin) and lipid peroxidation (thiobarbituric acid reactive substance). In transgenic mice with targeted cardiomyocyte expression of a CaMKII inhibitory peptide (AC3-I) or a scrambled control peptide (AC3-C), Iso treatment increased thiobarbituric acid reactive substance in both strains, whereas it increased CaMKII activity and apoptosis only in AC3-C mice. Endogenous increases in RAAS activity induce ROS and CaMKII-dependent apoptosis in vivo. CaMKII activation could not be associated with intracellular Ca(2+) increments and was directly related to the increase in oxidative stress.
1)肾素-血管紧张素-醛固酮系统(RAAS)的过度活跃是否会导致心脏病早期发生细胞凋亡;2)钙调蛋白依赖性蛋白激酶 II(CaMKII)是否参与这些凋亡事件。在心脏病的早期阶段使用了两种肥大模型:自发性高血压大鼠(SHR)和异丙肾上腺素处理大鼠(Iso-rats)。在 4 个月时,SHR 的血压、醛固酮血清水平(作为 RAAS 活性指数)和左心室质量指数(作为肥大指数)分别比对照组高 84.2±2.6mmHg、211.2±25.8%和 8.6±1.1mg/mm。还观察到凋亡增加(Bax-to-Bcl-2 比值和末端脱氧核苷酸转移酶 dUTP 介导的 nick-end 标记阳性细胞),同时 CaMKII 活性增强(磷酸化-CaMKII 比对照组高 98.7±14.1%)。在 4 个月大的 Iso-rats 中也观察到类似的结果。所有组的超声心动图研究均未改变心脏功能。依那普利治疗显著预防了肥大、凋亡和 CaMKII 活性。此外,在 SHR、Iso-rats 及其年龄匹配的对照组中,分离的心肌细胞内的 Ca2+处理相似。然而,SHR 和 Iso-rats 显示超氧阴离子生成(荧光素)和脂质过氧化(硫代巴比妥酸反应物质)的显著增加。在靶向表达 CaMKII 抑制肽(AC3-I)或随机对照肽(AC3-C)的转基因小鼠中,Iso 处理增加了两种菌株的硫代巴比妥酸反应物质,而仅在 AC3-C 小鼠中增加了 CaMKII 活性和凋亡。内源性 RAAS 活性的增加会导致体内 ROS 和 CaMKII 依赖性凋亡。CaMKII 的激活不能与细胞内 Ca2+的增加相关,而是与氧化应激的增加直接相关。